Literature DB >> 19458070

Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer.

Cristina G Viloria1, Alvaro J Obaya, Angela Moncada-Pazos, María Llamazares, Aurora Astudillo, Gabriel Capellá, Santiago Cal, Carlos López-Otín.   

Abstract

Matrix metalloproteinases have been traditionally linked to cancer dissemination through their ability to degrade most extracellular matrix components, thus facilitating invasion and metastasis of tumor cells. However, recent functional studies have revealed that some metalloproteases, including several members of the ADAMTS family, also exhibit tumor suppressor properties. In particular, ADAMTS1, ADAMTS9, and ADAMTS18 have been found to be epigenetically silenced in malignant tumors of different sources, suggesting that they may function as tumor suppressor genes. Herein, we show that ADAMTS15 is genetically inactivated in colon cancer. We have performed a mutational analysis of the ADAMTS15 gene in human colorectal carcinomas, with the finding of four mutations in 50 primary tumors and 6 colorectal cancer cell lines. Moreover, functional in vitro and in vivo studies using HCT-116 and SW-620 colorectal cancer cells and severe combined immunodeficient mice have revealed that ADAMTS15 restrains tumor growth and invasion. Furthermore, the presence of ADAMTS15 in human colorectal cancer samples showed a negative correlation with the histopathologic differentiation grade of the corresponding tumors. Collectively, these results provide evidence that extracellular proteases, including ADAMTS15, may be targets of inactivating mutations in human cancer and further validate the concept that secreted metalloproteases may show tumor suppressor properties.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458070     DOI: 10.1158/0008-5472.CAN-08-4155

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

Review 1.  Delving into somatic variation in sporadic melanoma.

Authors:  Vijay Walia; Euphemia W Mu; Jimmy C Lin; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

2.  ADAMTS13 and 15 are not regulated by the full length and N-terminal domain forms of TIMP-1, -2, -3 and -4.

Authors:  Cenqi Guo; Anastasia Tsigkou; Meng Huee Lee
Journal:  Biomed Rep       Date:  2015-10-30

3.  New negative feedback regulators of Egfr signaling in Drosophila.

Authors:  Jonathan P Butchar; Donna Cain; Sathiya N Manivannan; Andrea D McCue; Liana Bonanno; Sarah Halula; Sharon Truesdell; Christina L Austin; Thomas L Jacobsen; Amanda Simcox
Journal:  Genetics       Date:  2012-05-17       Impact factor: 4.562

4.  Mutational and functional analysis reveals ADAMTS18 metalloproteinase as a novel driver in melanoma.

Authors:  Xiaomu Wei; Todd D Prickett; Cristina G Viloria; Alfredo Molinolo; Jimmy C Lin; Isabel Cardenas-Navia; Pedro Cruz; Steven A Rosenberg; Michael A Davies; Jeffrey E Gershenwald; Carlos López-Otín; Yardena Samuels
Journal:  Mol Cancer Res       Date:  2010-10-13       Impact factor: 5.852

Review 5.  A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms.

Authors:  Suneel S Apte
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

6.  Identification of novel tumor suppressor proteases by degradome profiling of colorectal carcinomas.

Authors:  Julia M Fraile; Gonzalo R Ordóñez; Pedro M Quirós; Aurora Astudillo; José A Galván; Dolors Colomer; Carlos López-Otín; José M P Freije; Xose S Puente
Journal:  Oncotarget       Date:  2013-09-15

7.  Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.

Authors:  Todd D Prickett; Xiaomu Wei; Isabel Cardenas-Navia; Jamie K Teer; Jimmy C Lin; Vijay Walia; Jared Gartner; Jiji Jiang; Praveen F Cherukuri; Alfredo Molinolo; Michael A Davies; Jeffrey E Gershenwald; Katherine Stemke-Hale; Steven A Rosenberg; Elliott H Margulies; Yardena Samuels
Journal:  Nat Genet       Date:  2011-09-25       Impact factor: 38.330

8.  Epigenetic silencing of ADAMTS5 is associated with increased invasiveness and poor survival in patients with colorectal cancer.

Authors:  Jizhen Li; Yi Liao; Jintuan Huang; Yi Sun; Hao Chen; Chunyu Chen; Senmao Li; Zuli Yang
Journal:  J Cancer Res Clin Oncol       Date:  2017-11-15       Impact factor: 4.553

9.  Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma.

Authors:  Xiaomu Wei; Angela Moncada-Pazos; Santiago Cal; Clara Soria-Valles; Jared Gartner; Udo Rudloff; Jimmy C Lin; Steven A Rosenberg; Carlos López-Otín; Yardena Samuels
Journal:  Hum Mutat       Date:  2011-02-24       Impact factor: 4.878

10.  Transcriptomic Profiling of Medial Temporal Lobe Epilepsy.

Authors:  Abhilash K Venugopal; Ghantasala S Sameer Kumar; Anita Mahadevan; Lakshmi Dhevi N Selvan; Arivusudar Marimuthu; Jyoti Bajpai Dikshit; Pramila Tata; Yl Ramachandra; Raghothama Chaerkady; Sanjib Sinha; Ba Chandramouli; A Arivazhagan; Parthasarathy Satishchandra; Sk Shankar; Akhilesh Pandey
Journal:  J Proteomics Bioinform       Date:  2012-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.